
Full profile: /officials/P000048
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-06-04
Source: Congress.gov
Currently in
Previously
This bill aims to support smaller biotechnology companies by likely providing tax breaks, regulatory relief, or funding to help them develop new medicines and treatments more easily. The changes would reduce some of the financial and bureaucratic barriers that small biotech firms face compared to large pharmaceutical companies, potentially speeding up innovation in areas like rare diseases or personalized medicine. The bill is currently being reviewed by two congressional committees to determine which parts fall under their respective responsibilities.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.